Does BLONANSERIN Cause Decreased appetite? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Decreased appetite have been filed in association with BLONANSERIN. This represents 4.5% of all adverse event reports for BLONANSERIN.
11
Reports of Decreased appetite with BLONANSERIN
4.5%
of all BLONANSERIN reports
1
Deaths
6
Hospitalizations
How Dangerous Is Decreased appetite From BLONANSERIN?
Of the 11 reports, 1 (9.1%) resulted in death, 6 (54.5%) required hospitalization.
Is Decreased appetite Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BLONANSERIN. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does BLONANSERIN Cause?
Drug ineffective (21)
Schizophrenia (21)
Somnolence (21)
Hallucination, auditory (18)
Off label use (16)
Agitation (14)
Pneumonia aspiration (14)
Psychiatric symptom (14)
Insomnia (12)
Parkinsonism (12)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which BLONANSERIN Alternatives Have Lower Decreased appetite Risk?
BLONANSERIN vs --BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1
BLONANSERIN vs BOCEPREVIR
BLONANSERIN vs BOCOCIZUMAB
BLONANSERIN vs BONIVA
BLONANSERIN vs BONVIVA